LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 3 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $66,092 | +182.9% | 1,103 | +240.4% | 0.00% | +100.0% |
Q2 2023 | $23,360 | +61373.7% | 324 | -37.6% | 0.00% | 0.0% |
Q1 2023 | $38 | -51.3% | 519 | -55.3% | 0.00% | -66.7% |
Q4 2022 | $78 | -100.0% | 1,161 | -66.8% | 0.00% | -40.0% |
Q3 2022 | $301,000 | -39.8% | 3,492 | -37.7% | 0.01% | -54.5% |
Q2 2022 | $500,000 | +147.5% | 5,601 | +211.9% | 0.01% | +450.0% |
Q1 2022 | $202,000 | -63.5% | 1,796 | -49.9% | 0.00% | -80.0% |
Q4 2021 | $554,000 | +179.8% | 3,587 | +152.8% | 0.01% | +100.0% |
Q3 2021 | $198,000 | +47.8% | 1,419 | +39.0% | 0.01% | +66.7% |
Q2 2021 | $134,000 | -21.6% | 1,021 | -8.9% | 0.00% | 0.0% |
Q1 2021 | $171,000 | +98.8% | 1,121 | +29.1% | 0.00% | 0.0% |
Q4 2020 | $86,000 | -30.1% | 868 | -33.0% | 0.00% | +200.0% |
Q3 2020 | $123,000 | -68.5% | 1,295 | -62.9% | 0.00% | -93.8% |
Q2 2020 | $390,000 | +19400.0% | 3,491 | +11536.7% | 0.02% | – |
Q1 2020 | $2,000 | -99.1% | 30 | -98.7% | 0.00% | -100.0% |
Q4 2019 | $232,000 | +792.3% | 2,227 | +759.8% | 0.02% | +850.0% |
Q3 2019 | $26,000 | 0.0% | 259 | +13.6% | 0.00% | 0.0% |
Q2 2019 | $26,000 | +160.0% | 228 | +188.6% | 0.00% | +100.0% |
Q1 2019 | $10,000 | -63.0% | 79 | -60.3% | 0.00% | -50.0% |
Q4 2018 | $27,000 | +800.0% | 199 | +1226.7% | 0.00% | – |
Q2 2018 | $3,000 | -85.0% | 15 | -89.6% | 0.00% | -100.0% |
Q4 2017 | $20,000 | -89.8% | 144 | -90.0% | 0.00% | -81.2% |
Q3 2017 | $197,000 | +579.3% | 1,445 | +514.9% | 0.02% | +433.3% |
Q2 2017 | $29,000 | +45.0% | 235 | +20.5% | 0.00% | +50.0% |
Q4 2016 | $20,000 | +81.8% | 195 | +74.1% | 0.00% | +100.0% |
Q3 2016 | $11,000 | -21.4% | 112 | -7.4% | 0.00% | 0.0% |
Q2 2016 | $14,000 | -22.2% | 121 | -27.5% | 0.00% | -66.7% |
Q4 2015 | $18,000 | -43.8% | 167 | -47.5% | 0.00% | 0.0% |
Q2 2015 | $32,000 | -74.4% | 318 | -80.4% | 0.00% | -80.0% |
Q1 2015 | $125,000 | +681.2% | 1,622 | +440.7% | 0.02% | +650.0% |
Q4 2014 | $16,000 | +23.1% | 300 | +9.5% | 0.00% | +100.0% |
Q3 2014 | $13,000 | -74.5% | 274 | -66.5% | 0.00% | -85.7% |
Q2 2014 | $51,000 | +240.0% | 819 | +265.6% | 0.01% | +250.0% |
Q1 2014 | $15,000 | +1400.0% | 224 | +729.6% | 0.00% | – |
Q3 2013 | $1,000 | -98.8% | 27 | -98.8% | 0.00% | -100.0% |
Q2 2013 | $86,000 | – | 2,302 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knott David M Jr | 115,000 | $7,682 | 2.90% |
VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |